20 research outputs found
Is asthma a risk factor for COVID-19? Are phenotypes important?
Asthma is a major health problem all over the world [1]. Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory pathogen, it is important to quantify the risk that the current coronavirus disease 2019 (COVID-19) pandemic may represent for patients with asthma. These results reaffirm the idea that asthma does not appear to be a risk factor for the development of #COVID19. However, most of the asthma patients in this study had a non-T2 phenotype
Is asthma a risk factor for COVID-19? Are phenotypes important?
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Infeccions respiratĂČries i tuberculosi; Asma i al·lĂšrgiaCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; COVID-19; Infecciones respiratorias y tuberculosis; Asma y alergiaCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Respiratory infections and tuberculosis; Asthma and allergyThese results reaffirm the idea that asthma does not appear to be a risk factor for the development of #COVID19. However, most of the asthma patients in this study had a non-T2 phenotype
Risk factors for the development of bronchiectasis in patients with asthma
Asthma; Medical researchAsma; InvestigaciĂłn mĂ©dicaAsma; Recerca mĂšdicaThough asthma and bronchiectasis are two different diseases, their coexistence has been demonstrated in many patients. The aim of the present study is to compare the characteristics of asthmatic patients with and without bronchiectasis and to assess risk factors for the development of this condition. Two hundred and twenty-four moderate-severe asthmatic patients were included. The severity of bronchiectasis was assessed by Reiff and FACED parameters. Logistic regression was used to identify independent factors associated with bronchiectasis. Bronchiectasis was identified in 78 asthma patients. In severe asthma patients, its prevalence was 56.9%. Bronchiectasis was defined as mild in81% of patients using modified Reiff criteria and in 74% using FACED criteria. Asthmatic patients with bronchiectasis had decreasing FEV1, FVC and FEV1/FVC (pâ=â0.002, 0.005 and 0.014 respectively), presented more frequent asthma exacerbations (pâ<â0.001) and worse asthma control (ACT 21 vs 16pts, pâ<â0.001). Factors independently associated with bronchiectasis were older age (42â65 years: OR, 3.99; 95% CI 1.60 to 9.95, Pâ=â0.003;ââ„â65 years: OR, 2.91; 95% CI 1.06 to 8.04, Pâ=â0.039), severe asthma grade (OR, 8.91; 95% CI 3.69 to 21.49; Pâ<â0.001) and frequency of asthma exacerbations (OR, 4.43; 95% CI 1.78 to 11.05; Pâ<â0.001). In patients with severe asthma, age of asthma onset (OR, 1.02; 95% CI 1.01 to 1.04; Pâ=â0.015) and asthma exacerbations (OR, 4.88; 95% CI 1.98 to 12.03; Pâ=â0.001) were independently associated with the development of bronchiectasis. The prevalence of bronchiectasis in severe asthmatic patients is high. Age of asthma onset and exacerbations were independent factors associated with the occurrence of bronchiectasis.The study was partially supported by FIS PI15/01900 (Fondo Europeo de Desarrollo Regional (FEDER) and Fundacio Catalana de PneumologĂa (FUCAP). MJC is supported by the Miguel Servet program of the Instituto de Salud Carlos III (MSII17/00025). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Sensitization to avian and fungal proteins in different work environments
Birds; Fungi; Hypersensitivity pneumonitisOcells; Fongs; Pneumonitis per hipersensibilitatAves; Hongos; Neumonitis por hipersensibilidadIntroduction
Hypersensitivity pneumonitis (HP) is usually caused by the inhalation of avian and fungal proteins. The present study assesses a cohort of Urban Pest Surveillance and Control Service (UPSCS) workers with high exposure to avian and fungal antigens, in order to identify their degree of sensitization and the potential risk of developing HP.
Methods
Workers were divided according to their work activity into Nest pruners (Group 1) and Others (Group 2). All individuals underwent a medical interview, pulmonary function tests and the determination of specific IgG antibodies. Antigenic proteins of pigeon sera were analysed using two-dimensional immunoblotting. Proteins of interest were sequenced by liquid-chromatographyâmass spectrometry (LCâMS).
Results
101 workers were recruited (76 men, average age: 42 yrs); (Group 1â=â41, Group 2â=â60). Up to 30% of the study population exhibited increased levels of IgGs to pigeon, small parrot and parrot, and up to 60% showed high levels of Aspergillus and Penicillium IgGs. In Group 1, specific parakeet and Mucor IgGs were higher (pâ=â0.044 and 0.003 respectively) while DLCO/VA% were lower (pâ=â0.008) than in Group 2. Two-dimensional immunoblotting showed protein bands of 20â30 KDa recognized by HP patients but not by workers. LCâMS analysis identified Ig Lambda chain and Apolipoprotein A-I as candidate proteins for distinguishing HP patients from exposed workers.
Conclusions
Two pigeon proteins were identified that may play a role in the development of pathological differences between HP patients and exposed workers. DLCO/VA may have a predictive value in the development of HP disease.SSD is a researcher supported by CIBER, MJC is supported by the Miguel Servet program of the Instituto de Salud Carlos III (MSII17/00025) and IO is a researcher supported by the Pla Estrategic de Recerca i Innovaciâen Salut (PERIS) 2016â2020 (SLT008/18/00108; G60594009). This project received funding from FIS PI PI15/01954, Fondo Europeo de Desarrollo Regional (FEDER), FundaciĂł Catalana de Pneumologia (FUCAP) and Sociedad Española de PatologĂa respiratoria (SEPAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Influence of the environment on the characteristics of asthma
Environmental sciences; Health careCiĂšncies ambientals; AtenciĂł sanitĂ riaCiencias Ambientales; AtenciĂłn sanitariaFew studies have compared the prevalence of asthma in urban and rural settings or explored the issue of whether these two manifestations of the disease may represent different phenotypes. The aim of this study was: (a) to establish whether the prevalence of asthma differs between rural and urban settings, and b) to identify differences in the clinical presentation of asthma in these two environments. Descriptive epidemiological study involving individuals aged 18 or over from a rural (nâ=â516) and an urban population (nâ=â522). In the first phase, individuals were contacted by letter in order to organize the administration of a first validated questionnaire (Q1) designed to establish the possible prevalence of bronchial asthma. In the second phase, patients who had presented association patterns in the set of variables related to asthma in Q1 completed a second validated questionnaire (Q2), designed to identify the characteristics of asthma. According to Q1, the prevalence of asthma was 15% (nâ=â78) and 11% (nâ=â59) in rural and urban populations respectively. Sixty-five individuals with asthma from the rural population and all 59 individuals from the urban population were contacted and administered the Q2. Thirty-seven per cent of the individuals surveyed had previously been diagnosed with bronchial asthma (35% in the rural population and 40% in the urban setting). In the urban asthmatic population there was a predominance of women, a greater personal history of allergic rhinitis and a family history of allergic rhinitis and/or eczema. Asthma was diagnosed in adulthood in 74.8% of the patients, with no significant differences between the two populations. Regarding symptoms, cough (morning, daytime and night) and expectoration were more frequent in the urban population. The prevalence of asthma does not differ between urban and rural settings. The differences in exposure that characterize each environment may lead to different manifestations of the disease and may also affect its severity.MJC is supported by the Miguel Servet program of the Instituto de Salud Carlos III (MSII17/00025). This project received funding from the FundaciĂł Catalana de Pneumologia (FUCAP), FIS PI18/00344, Fondo Europeo de Desarrollo Regional (FEDER) and Menarini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Near-normal aerobic capacity in long-term survivors after lung transplantation
Lung transplant; Survivors; Aerobic capacityTrasplantaments de pulmĂł; Supervivents; Capacitat aerĂČbicaTrasplantes de pulmĂłn; Supervivientes; Capacidad aerĂłbicaThe clinical course of lung transplantation (LT) is diverse: some patients present chronic lung allograft dysfunction (CLAD) and progressive decline in pulmonary function, but others maintain normal spirometric values and active lives. Objectives The aim of this study was to elucidate whether long-term LT survivors with normal spirometry achieve normal exercise capacity, and to identify predictive factors of exercise capacity. Methods This was a cross-sectional multicentre study, where bilateral LT recipients who survived at least 10â
years after LT, with normal spirometry, no diagnosis of CLAD and modified Medical Research Council dyspnoea degree â€2 underwent cardiopulmonary exercise testing (CPET). Results 28 LT recipients were included with a mean±sd age of 48.7±13.6â
years. Oxygen uptake (VâČO2) had a mean±sd value of 21.49±6.68â
mL·kgâ1·minâ1 (75.24±15.6%) and the anaerobic threshold was reached at 48.6±10.1% of the VâČO2max predicted. The mean±sd heart rate reserve at peak exercise was 17.56±13.6%. The oxygen pulse increased during exercise and was within normal values at 90.5±19.4%. The respiratory exchange ratio exceeded 1.19 at maximum exercise. The median (25â75th percentile) EuroQol-5D score was 1 (0.95â1), indicating a good quality of life. The median (25â75th percentile) International Physical Activity Questionnaire score was 5497 (4007â9832)â
MET-min·weekâ1 with 89% of patients reporting more than 1500â
MET-min·weekâ1. In the multivariate regression models, age, sex and diffusing capacity of the lung for carbon monoxide remained significantly associated with VâČO2max (mL·kgâ1·minâ1); haemoglobin and forced expiratory volume in 1â
s were significantly associated with maximum work rate (watts), after adjusting for confounders. Conclusion We report for the first time near-normal peak VâČO2 values during CPET and normal exercise capacity in long-term LT recipients without CLAD.Support statement: This study was financed by Instituto de Salud Carlos III (PI13/01076); the European Regional Development Fund (FEDER), FUCAP, Astellas, Novartis and Chiesi. Funding information for this article has been deposited with the Crossref Funder Registry.Ojanguren is a researcher supported by the âPla EstratĂšgic de Recerca i InnovaciĂł en Salut (PERIS)â 2016â2020 (SLT008/18/00108;G60594009)
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19 : a randomised clinical trial
SARS-CoV-2 vaccines have been extremely effective to reduce the incidence of severe COVID19 [1-3], but effective and safe treatments of the acute infection are still limited [4, 5]. An uncontrolled pulmonary inflammatory response to SARS-CoV-2 is considered a key pathogenic mechanism of COVID19 progression [6], so systemic dexamethasone is recommended in severe cases [5, 7]. On the other hand, in very mild patients at home inhaled corticosteroids (ICS) may prevent disease progression [8-11]. Whether ICS prevent disease progression too in patients hospitalised because of COVID19 has not been explored before. Accordingly, we designed an investigator-initiated, open-label, randomised clinical trial (RCT) to explore the efficacy of adding inhaled budesonide to usual care to prevent disease progression in patients hospitalised because of COVID19 pneumonia. We also monitored carefully the safety of this intervention since there are concerns about the use of systemic corticosteroids in other viral (influenza) lung infections [12]
Influence of the environment on the characteristics of asthma
Abstract Few studies have compared the prevalence of asthma in urban and rural settings or explored the issue of whether these two manifestations of the disease may represent different phenotypes. The aim of this study was: (a) to establish whether the prevalence of asthma differs between rural and urban settings, and b) to identify differences in the clinical presentation of asthma in these two environments. Descriptive epidemiological study involving individuals aged 18 or over from a rural (nâ=â516) and an urban population (nâ=â522). In the first phase, individuals were contacted by letter in order to organize the administration of a first validated questionnaire (Q1) designed to establish the possible prevalence of bronchial asthma. In the second phase, patients who had presented association patterns in the set of variables related to asthma in Q1 completed a second validated questionnaire (Q2), designed to identify the characteristics of asthma. According to Q1, the prevalence of asthma was 15% (nâ=â78) and 11% (nâ=â59) in rural and urban populations respectively. Sixty-five individuals with asthma from the rural population and all 59 individuals from the urban population were contacted and administered the Q2. Thirty-seven per cent of the individuals surveyed had previously been diagnosed with bronchial asthma (35% in the rural population and 40% in the urban setting). In the urban asthmatic population there was a predominance of women, a greater personal history of allergic rhinitis and a family history of allergic rhinitis and/or eczema. Asthma was diagnosed in adulthood in 74.8% of the patients, with no significant differences between the two populations. Regarding symptoms, cough (morning, daytime and night) and expectoration were more frequent in the urban population. The prevalence of asthma does not differ between urban and rural settings. The differences in exposure that characterize each environment may lead to different manifestations of the disease and may also affect its severity
Immunopathological Mechanisms of Bird-Related Hypersensitivity Pneumonitis
Bird-related hypersensitivity pneumonitis (BRHP) is an interstitial lung disease induced by avian proteins. The immunopathological pathways involved in the disease are still unknown. This study assesses the cellular immune response and the cytokine pattern in a mouse model of BRHP. On days −3 and −1, mice were intraperitoneally sensitized with commercial pigeon serum (PS) or saline. Intranasal instillations with PS or saline were carried out on three consecutive days/week over either 3 weeks (Group 1) or 12 weeks (Group 2). Leukocyte and cytokine patterns in lung tissue and pulmonary inflammation in bronchoalveolar lavage (BAL) were analysed. Both groups presented increases in resident monocytes, interstitial macrophages and type 2 dendritic cells (DCs), but also reductions in inflammatory monocytes, alveolar macrophages and tolerogenic DCs compared with their control groups. Group 1 had increased levels of eosinophils and T cells with reductions in neutrophils and B cells, while Group 2 showed high levels of B cells. Both groups exhibited increases in Th1 and Th2 cytokines. Group 2 also showed increased levels of IL-23, a Th17 cytokine. Increased levels of neutrophils, eosinophils and lymphocytes were observed in BAL samples of both groups compared with controls. In the first stages of BRHP, there is a mixed Th1/Th2 immune response, while during the progression of the disease, although there is a Th1 response, the cytokine levels seem to indicate a switch towards a Th2/Th17 mixed response
Influence of the environment on the characteristics of asthma
Few studies have compared the prevalence of asthma in urban and rural settings or explored the issue of whether these two manifestations of the disease may represent different phenotypes. The aim of this study was: (a) to establish whether the prevalence of asthma differs between rural and urban settings, and b) to identify differences in the clinical presentation of asthma in these two environments. Descriptive epidemiological study involving individuals aged 18 or over from a rural (n = 516) and an urban population (n = 522). In the first phase, individuals were contacted by letter in order to organize the administration of a first validated questionnaire (Q1) designed to establish the possible prevalence of bronchial asthma. In the second phase, patients who had presented association patterns in the set of variables related to asthma in Q1 completed a second validated questionnaire (Q2), designed to identify the characteristics of asthma. According to Q1, the prevalence of asthma was 15% (n = 78) and 11% (n = 59) in rural and urban populations respectively. Sixty-five individuals with asthma from the rural population and all 59 individuals from the urban population were contacted and administered the Q2. Thirty-seven per cent of the individuals surveyed had previously been diagnosed with bronchial asthma (35% in the rural population and 40% in the urban setting). In the urban asthmatic population there was a predominance of women, a greater personal history of allergic rhinitis and a family history of allergic rhinitis and/or eczema. Asthma was diagnosed in adulthood in 74.8% of the patients, with no significant differences between the two populations. Regarding symptoms, cough (morning, daytime and night) and expectoration were more frequent in the urban population. The prevalence of asthma does not differ between urban and rural settings. The differences in exposure that characterize each environment may lead to different manifestations of the disease and may also affect its severit